Since the Firm’s founding, Longwood Fund, and its principals, have been active in co-founding leading biotechs serving in company leadership roles as well as lead investor, and anticipates being ...

Longwood Fund is topping up its coffers with $170 million for its fifth biotech-building fund. Aptly dubbed Fund V, it is nearly double the VC shop’s first fund of $85 million, raised in 2010.

LEVERKUSEN, Germany and BOSTON, July 17, 2019 /PRNewswire/ -- Pyxis Oncology ("Pyxis"), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody ...

Longwood Fund to narrow its focus with new $180M fund. expand. Courtesy photos. By Rowan Walrath – Life Sciences Reporter, Boston Business Journal. May 4, 2023. Preview this article 1 min.

In February 2010, the Fund made its first investment in Alnara Pharmaceuticals, Inc., a company co-founded by members of the Longwood team and Dr. Alexey Margolin.Alnara’s lead drug, liprotamase ...

Logo BOSTON - September 8, 2022 - (Newswire.com) Longwood Fund, an early-stage life science venture firm focused on company creation, will convene several hundred top biotech and pharmaceutical ...